VEGFA and metabolic dysfunction-associated steatotic liver disease: Kyoto Encyclopedia of Genes and Genomes results suggested that the enrichment pathways included VEGF signaling pathway, tumor necrosis factor (TNF) signaling pathway, non-alcoholic fatty liver disease (NAFLD), lipid and atherosclerosis, hypoxia inducible factor (HIF)-1 signaling pathway, hepatitis B, drug metabolism—CYP450, chemokine signaling pathway, apoptosis, and ARA metabolism (Figure 7D).